Partnerships are a key component in the operating playbook of emerging and developing biotechnology companies. Although this year is shaping up as a very big one for deals, according to data from the Biotechnology Industry Organization (BIO) and biopharma consulting firm Campbell Alliance Group, they are not as lucrative for generating cash in the early stages as they once were. Read More
A report from real estate firm Jones Lang LaSalle in March lists San Diego as the number two biotechnology cluster in the U.S. Like any list, the ranking is debatable, especially by people in the San Francisco Bay Area who came in third. But whether the region is ranked first, second, or third, it's pretty clear San Diego and the rest of Southern California is an important region for the biotech industry. Read More
By taking a detailed look at toxicities of a bispecific antibody that targets the transferrin receptor to cross the blood-brain-barrier, researchers at Genentech Inc. have gained new insights into both "important safety concerns and potential mitigation strategies" for the therapeutic development of such antibodies. Read More
